Your browser doesn't support javascript.
loading
Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster, Jason W; Matthews, S James.
Affiliation
  • Lancaster JW; Department of Pharmacy Practice, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Clin Ther ; 34(1): 1-13, 2012 Jan.
Article in En | MEDLINE | ID: mdl-22284993
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enterocolitis, Pseudomembranous / Clostridioides difficile / Aminoglycosides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Clin Ther Year: 2012 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enterocolitis, Pseudomembranous / Clostridioides difficile / Aminoglycosides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Clin Ther Year: 2012 Document type: Article Affiliation country: Estados Unidos